Immunology Products & Reviews

CD-Chex CD103 Plus is a positive flow cytometry control for CD103, CD30, CD38, CD56, CD138 and cytoplasmic Lambda expression.  

The award-winning DxI 9000 Analyzer sets a new standard for today’s busy labs. With meaningful innovations that amplify your impact, liberate you from the laborious, and power your performance across your health system, this high-throughput immunoassay analyzer takes diagnostics to the next level.

High sensitivity, specificity, and accuracy

Approved by ANSM in France

Confirm and Differentiate HIV-1 and HIV-2

Fully automated system

in vitro detection of antibodies to HIV-1 and HIV-2

Approved by Health Authorities in many European Countries

Detection of both current and past infection with H. pylori

The Steroid Panel Tec-Trace includes one set of calibrators, quality controls and internal standard.

Wieslab Diagnostic Services offers a comprehensive range of individual markers and test panels for autoimmune diseases. We offer fast turnaround times and access to a medical specialist to discuss your results.

Wieslab Diagnostic Services offers therapeutic drug monitoring (TDM) for a range of biopharmaceuticals.

Wieslab Diagnostic Services offers a comprehensive range of individual markers and test panels and welcomes samples from customers worldwide. Wiselab's request forms list test panels and individual tests currently available in the areas of Autoimmunity, Neurology, and Monitoring of Biopharmaceuticals. We offer fast turnaround times and access to a medical specialist to discuss your results.

Cellpuri® is a disposable chip that enriches cells without the use of centrifugation method. Cells are being separated using the rheological phenomenon inside the microchannels where the cell suspension pass through to filter out waste medium and collect the enriched cells in the outlet.

Monoclonal and polyclonal antibodies with validated performance for the precise detection of disease biomarkers in a wide range of clinical and research immunoassays.

The Small Giant: AIA®-CL300, the new benchtop automated immunoassay analyser of Tosoh Bioscience – Diagnostics launched in May 2023, is the solution to meet specific needs from small to large laboratories. This innovative automatic analyser is ideal to perform routine analysis, cover emergency use, run specific pathologies and esoteric tests.

Powerful and Flexible Immunoassay Testing: The AIA®-CL2400 is Tosoh’s highest productivity immunoassay analyser, ideal for large hospitals and clinics, reference and core labs. Like all other Tosoh AIA®-CL automated immunoassay analysers, utilises the unique CL-AIA Pack twin cup format. With a throughput of up to 240 results per hour and assay time of 15 minutes for most analytes, this instrument is suited to a high level of w…

Powerful and Flexible Immunoassay Testing: The AIA®-CL1200 is the mid-size analyser, ideal for medium and large hospitals and clinics, reference labs and core labs. With a throughput of up to 120 results/h, assay time of 15 min for most analytes, advanced automation features, and excellent analytical performance, it offers a unique solution to labs and it improves patient outcomes.

Metabolic Assays.

Clinical flow cytometer for immunophenotyping

Lightweight and designed to fit comfortably in either hand.

Monoclonal Anti-Claudin-18.2 Antibody, Mouse IgG1 (3B10) was developed to be exquisitely CLDN18.2 specific, characterized as not cross-reacting with CLDN18.1 and without background staining.

OXM causes weight loss via suppression of food intake and increase in energy expenditure. OXM administration was also reported to increase heart-rate in mice. Besides regulating glucose homeostasis in monogastric animals, OXM also increases the concentration of insulin and glucose in plasma of Holstein cattle under normal physiological conditions. It has been shown that Type 2 diabetes patients have lower levels of OXM and lev…

The Ansh Labs Bioactive IGF-I kit uses a highly sensitive two-site antibody method which allows detection of bioactive IGF-I. This assay enables accurate measurement and differentiation of bioactive IGF-I from total IGF-I levels. Assessment of bioactive to total IGF-I ratio will be informative and advance our understanding of IGF-I function and regulation in different physiological and disease states.

The Total IGF-I immunoassay is a direct detection method which eliminates potential altering of sample matrix from size-exclusion chromatography or filtration methods.